Suchergebnisse - "Bongard, Emily"

PubPharm (63)

41

Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial

enthalten in: The British journal of cancer | 2017

von Neal, R. | Barham, A. | Bongard, E. | +15

42

Point of care testing for urinary tract infection in primary care (POETIC) : protocol for a randomised controlled trial of the clinical and cost effectiveness of FLEXICULT™ informed management of uncomplicated UTI in primary care

enthalten in: BMC family practice | 2014

von Bates, J. | Thomas-Jones, E. | Pickles, T. | +15

43

Point of care testing for urinary tract infection in primary care (POETIC): protocol for a randomised controlled trial of the clinical and cost effectiveness of FLEXICULT™ informed management of uncomplicated UTI in primary care

enthalten in: BMC family practice | 2014

von Bates, J. | Thomas-Jones, E. | Pickles, T. | +15

44

Point of care testing for urinary tract infection in primary care (POETIC): protocol for a randomised controlled trial of the clinical and cost effectiveness of FLEXICULT™ informed management of uncomplicated UTI in primary care

enthalten in: BMC family practice | 2014

von Bates, J. | Thomas-Jones, E. | Pickles, T. | +15

45

Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice

enthalten in: Trials | 2013

von Bates, J. | Thomas-Jones, E. | Kirby, N. | +11

46

Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice

enthalten in: Trials | 2013

von Bates, J. | Thomas-Jones, E. | Kirby, N. | +11

47

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2012

von Yuthavong, Y. | Tarnchompoo, B. | Vilaivan, T. | +16

48

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2012

von Yuthavong, Y. | Tarnchompoo, B. | Vilaivan, T. | +16

49

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

Erschienen: 2012

von Yuthavong, Y. | Tarnchompoo, B. | Vilaivan, T. | +16

50

Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents

enthalten in: European journal of medicinal chemistry | 2008

von Vicente, E. | Lima, L. | Bongard, E. | +8